BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22714920)

  • 1. Syndecan-1 expression in human glioma is correlated with advanced tumor progression and poor prognosis.
    Xu Y; Yuan J; Zhang Z; Lin L; Xu S
    Mol Biol Rep; 2012 Sep; 39(9):8979-85. PubMed ID: 22714920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and prognostic value of PAX3 expression in human glioma.
    Chen J; Xia L; Wu X; Xu L; Nie D; Shi J; Xu X; Ni L; Ju S; Wu X; Zhu H; Shi W
    J Mol Neurosci; 2012 May; 47(1):52-8. PubMed ID: 22231626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of FAT10 is correlated with progression and prognosis of human glioma.
    Yuan J; Tu Y; Mao X; He S; Wang L; Fu G; Zong J; Zhang Y
    Pathol Oncol Res; 2012 Oct; 18(4):833-9. PubMed ID: 22402871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
    Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
    Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression level of human miR-34a correlates with glioma grade and prognosis.
    Gao H; Zhao H; Xiang W
    J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.
    Wang L; Qin H; Li L; Zhang Y; Tu Y; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
    Med Oncol; 2012 Dec; 29(5):3491-7. PubMed ID: 22926920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.
    Wang S; Lu S; Geng S; Ma S; Liang Z; Jiao B
    Med Oncol; 2013 Mar; 30(1):373. PubMed ID: 23292865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of microRNA-372 upregulation with poor prognosis in human glioma.
    Li G; Zhang Z; Tu Y; Jin T; Liang H; Cui G; He S; Gao G
    Diagn Pathol; 2013 Jan; 8():1. PubMed ID: 23298385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microRNA-335 expression is associated with poor prognosis in human glioma.
    Jiang J; Sun X; Wang W; Jin X; Bo X; Li Z; Bian A; Jiu J; Wang X; Liu D; Hui X; Wang Y; Wang A; Ding L
    Med Oncol; 2012 Dec; 29(5):3472-7. PubMed ID: 22644918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of miR-3653 in glioma and its correlations with clinical progression and patient survival.
    Chen Y; Li ZH; Liu X; Liu GX; Yang HM; Wu PF
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6596-6601. PubMed ID: 31378901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
    Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
    Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma.
    Wu Z; Wang L; Li G; Liu H; Fan F; Li Z; Li Y; Gao G
    Mol Cell Biochem; 2013 Dec; 384(1-2):263-8. PubMed ID: 24122417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
    Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
    Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
    Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
    Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine deaminase and adenosine kinase expression in human glioma and their correlation with glioma‑associated epilepsy.
    Huang J; He Y; Chen M; Du J; Li G; Li S; Liu W; Long X
    Mol Med Rep; 2015 Nov; 12(5):6509-16. PubMed ID: 26329539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of forkhead box protein C2 is related to poor prognosis in human gliomas.
    Wang YW; Yin CL; Zhang HY; Hao J; Yang YY; Liao H; Jiao BH
    Asian Pac J Cancer Prev; 2014; 15(24):10621-5. PubMed ID: 25605149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.